December 3，The "2019 Stake Sports BettingShaanxi Stake Sports BettingTop 100 Enterprises Release and the 8th Provincial Outstanding Entrepreneur Commendation and Famous Enterprises Entering Han Activities" sponsored by the Shaanxi Provincial Entrepreneurs Association were held in Hanzhong，The ranking list of Shaanxi’s top 100 enterprises in 2019 was released at the meeting，Read out the 8th Provincial Outstanding Entrepreneur Commendation Decision。Vice Governor Zhao Gang attended the meetingAlso gave a speech。Xiao Zhiqiang, deputy general manager of the group、Meng Xianghai, deputy manager of the Investment Management Department, attended the press conference。

Approved by Shaanxi Province Top 100 Enterprise Ranking and Approval Committee，Shaanxi Pharmaceutical Group was shortlistedNo. 16 on the list of "Top 100 Shaanxi Enterprises in 2019"，Compared to 2018，The ranking improved by 4 places。Facing increasing downward pressure on the economy、Drug prices dropped stake online sports bettingsharply、Stake Sports BettingIndustry competition is becoming increasingly fierce, etc.Disadvantages，Shaanxi Pharmaceutical Group is guided by Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era，Comprehensively implement the provincial party committee、Provincial Government on the Reform of State-owned Enterprises、Strategic deployment for the development of the pharmaceutical industry，Under the guidance of the State-owned Assets Supervision and Administration Commission，Focus on the main business of medicine and health，PositiveIn compliance with reform and industry development trends,Strengthen technological innovation、Management innovation and business model innovation，Strengthen equity acquisition，Accelerate Xi'an Janssen global supply chain、Northwestern Medicine Industrial Base、Construction of four key projects of Northwest Modern Pharmaceutical Logistics Center and Northwest International Traditional Stake Sports BettingChinese stake online sports bettingMedicine Industrial Park，Intensify efforts in mixed-ownership reform and shareholding reform，PromoteImplementation of the “Thirteenth Five-Year Plan”，Promote the group’s transformation, upgrading and high-quality development，Strive to catch up and surpass，Operating revenue in 2018 reached 206.3.6 billion yuan，14 year-on-year increase.26%，Compared to 10 of the top 100 enterprises in our province.The average growth rate of 81% is 3 higher.45 percentage points, making new contributions to Shaanxi’s pharmaceutical industry.